The U.S. is an “outlier” among Western nations in providing body-altering drugs and surgery to children who identify as transgender, as concern grows in the scientific community about the results of such treatments.
Described by many Democratic politicians as “gender-affirming care” for “trans kids,” puberty-blocking drugs and sex reassignment surgeries at a young age may not reduce psychological distress, and may have long-term and irreversible consequences that children cannot factor into their decision-making at a young age.
